Mucoid breast carcinomas: histology and prognosis. by Fentiman, I. S. et al.
British Joumal ofCancer (1997) 75(7), 1061-1065
© 1997 Cancer Research Campaign
Mucoid breast carcinomas: histology and prognosis
IS Fentiman, RR Millis, P Smith, JPM Ellul and 0 Lampejo*
ICRF Clinical Oncology Unit, Guy's Hospital, London SE1 9RT, UK
Summary In a series of 73 patients with mucoid breast carcinomas treated at Guy's Hospital between 1973 and 1989, 24 (33%) patients had
pure mucoid lesions and 49 (67%) had mixed mucoid carcinomas. The patients with pure mucoid cancers had significantly smaller tumours
and, among those in whom an axillary dissection was performed, mixed mucoid cancers were more likely to be associated with axillary nodal
metastases (46% vs 14%). After long-term follow-up of 64 patients, both relapse-free and overall survival were significantly better for those
with pure mucoid carcinomas, forwhom the 10-year actuarial overall survival was 100%. The overall proportion of the tumourthat was mucoid
was also positively associated with a more favourable prognosis in patients with mixed tumours. With such a good prognosis, patients with
pure mucoid carcinomas may not require systemic adjuvant therapy after adequate primary treatment.
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Mucoid carcinomas ofthe breast constitute arelatively rare special
type comprising 1-2% of all breast cancers (Lee et al, 1934;
Azzopardi, 1979). Such tumours are associated with a good prog-
nosis and usually occur in women aged over 60 years. Tumours of
special type, with a favourable prognosis, are being seen more
frequently in those countries in which there is a breast cancer
screening programme; hence the incidence of mucoid carcinomas
may rise. Small tumours with a favourable prognosis are suitable
for conservation therapy, but the need for axillary clearance and
radiotherapy has been questioned; the latter is being addressed in
the BASO 2 trial which is assessing the roles of radiotherapy and
tamoxifen in women with screen-detected and completely excised,
small well-differentiated breast cancers that have not metastasized
to axillary nodes.
Clinically, the diagnosis ofmucoid carcinoma may be suspected
because on palpation there is a 'delicate swish or crush of ajelly-
like structure under tension' (Halsted, 1915). Variously termed
colloid, gelatinous, myxomatous, mucinous and mucoid, these
lesions all contain epithelial-derived mucin (Saphir, 1941).
Mucin may be detected in a variety of breast tumours and
Saphir (1941) described four separate types with different behav-
iour: true mucoid, infiltrating ductal carcinoma with mucoid
features, signet ring cell carcinoma and intracystic papilloma with
mucoid features. At present, most pathologists restrict the term
mucoid carcinoma to the former two categories, i.e. pure mucoid
and mixed mucoid. The latter is defined as a tumour in which at
least 10% of the carcinoma is of mucoid type but this is mixed
with an infiltrating component ofa different type, usually ductal of
no specific type (NST) (NHSBSP, 1995).
Mucinous carcinomas have also been categorized according to
growthpattern (Capella etal, 1980). Type A tumours are composed
of malignant cells that are slightly more pleomorphic than type
B tumours and are arranged in small groups with abundant
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extra-cellular mucin and usually no intra-cellular mucin. In type B
tumours, the cells are more monomorphic, more prominent and
arranged in larger groups with less extra-cellular mucin, but intra-
cellular mucin is occasionally present. A high proportion oftype B
tumours are found to be argyrophylic. A small number of tumours
have an intermediate pattern (type AB). So far, no difference in
prognosis has been found between Type A and B tumours but there
is a difference between pure and mixed mucoid carcinomas.
For pure mucoid carcinoma, there is a good prognosis (Norris et
al, 1965), although it has been claimed that a more aggressive
behaviour is seen after long-term follow-up (Rosen et al, 1980;
Clayton et al, 1984). For mixed tumours, the presence ofa mucoid
element does not appear to improve the prognosis which is that of
the non-mucoid component.
To examine the clinicopathological features and long-term
prognosis of patients with mucoid carcinoma, a series of 73
patients with pure and mixed mucoid cancers has been studied in
order to evaluate the histological features and relate them to clin-
ical features and, when possible, to outcome in a series with a
median follow-up of 10.5 years (range 1-22.5 years).
PATIENTS AND METHODS
The records ofall patients diagnosed as having mucoid carcinomas
in the Breast Unit atGuy's Hospital during the period 1973-89 were
reviewed. During this time, 81 patients were reported as having a
mucoid carcinoma on biopsy. In eightpatients,only a needle core or
incision biopsy had been performed and these were excluded as, to
diagnose a pure mucoid carcinoma, the entire tumour should be
sampled. Thus, 73 patients were included in the study.
Clinical features recorded included age at diagnosis, age of
menarche and menopause, ifknown and applicable, use ofthe oral
contraceptive pill, age at first pregnancy and number of pregnan-
cies, past medical history of other malignancy and family history
of breast cancer in first-degree relatives. The length of history,
clinical size of the tumour, primary treatment, nodal status and
treatment were noted.
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Table 1 Characteristics of patients with pure mucoid and mucoid with
infiltrating carcinoma
Pure mucold Mucold + Infiltrating
carcinoma
n 24 49
Mean age at diagnosis (years) 62 ± 14.5 63 ± 14.2
(Range) (27-90) (27-94)
Median age (years) 65 65
Median length of symptoms 1 2
(months) (1-12) (1-120)
Premenopausal 5 (17%) 9 (18%)
Stage
Operable, node Negative 18 21
Operable, node Positive 3 18
Operable, nodes unknown 3 6
Locally advanced 0 2
Metastatic 0 2
Figures are mean ± standard deviation with range in parentheses.
Tumours were categorized into pure mucoid or mixed types,
depending on histological morphology. The appearance and
percentage of the mucoid component was recorded together with
the appearance ofany associated in situ carcinoma and the type and
grade of the accompanying infiltrating component in the mixed
carcinomas. Grimelius staining forargyrophyllia wasperformed on
all tumours. The influence of tumour histology on prognosis was
assessed by life table analysis (Kaplan andMeier, 1958).
Table 2 Treatment of patients with mucoid carcinoma
Pure mucoid Mixed mucoid
Operable cases
Mastectomy 18 29
Breast conservation 3 10
Excision ± tamoxifen 3 6
Advanced cases
Toilet surgery 0 1
Endocrinetherapy 0 2
Chemotherapy 0 1
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Figure 1 Relapse-free survival of patients with pure and mixed mucoid
carcinomas. X12 = 8.29, P= 0.004
RESULTS
There were 24 patients who had pure mucoid carcinomas, and 49
who had mixed mucoid carcinomas. As shown in Table 1, the
median age of the patients in both groups was 65 years, and there
were no differences in age at menarche or menopause. Ofpatients
with pure mucoid carcinomas, five (17%) were premenopausal,
as were nine (18%) of those with mixed mucoid lesions. The
median length of history before diagnosis was similar for patients
with pure and mixed mucoid carcinomas (1 and 2 months respec-
tively), and there were no differences in any of the other patient
characteristics.
All patients presented with palpable lumps and most were Stage
I or II tumours but, ofthose with mixed mucoid, two had Stage III
tumours and two stage IV compared with none ofthe patients with
pure mucoid carcinomas (Table 1). The pure mucoid carcinomas
were slightly smaller at presentation (mean diameter 2.17 vs 3.25
cm), and this difference was statistically significant (P = 0.01).
The treatment ofthe primary tumours is given in Table 2. Most
patients were treated by radical or modified radical mastectomy
(75% of patients with pure mucoid and 59% of those with mixed
mucoid carcinomas). After 1982, breast conservation treatment
(tumour excision, axillary clearance and radiotherapy) was used
more frequently. Of the operable patients with pure mucoid
lesions, 21 (88%) had an axillary clearance as part of breast
conservation or mastectomy as did 39 (87%) ofthe mixed mucoid
group. Axillary nodal metastases were present in 18 (46%) of the
mixed group and three (14%) of the pure mucoid cases (Fisher's
exact test P = 0.016). In the mixed group, one patient was treated
by breast irradiation and another was given tamoxifen after
tumorectomy, as part ofa randomized trial.
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Relapse-free survival was assessed on 64 of the operable cases
(21 pure, 43 mixed). Four patients with previous non-mucoid
contralateral primary mammary carcinomas and one patient who
refused any treatment after her excisional biopsy were excluded
fromfollow-up analysis. The median length offollow-up was 10.5
years (range 1-22.5 years) and 24 patients had a follow-up greater
than 10 years (10 with pure mucoid carcinomas and 14 with mixed
tumours).
Figure 1 shows the relapse-free survival of patients with pure
mucoid carcinomas compared with those with mixed lesions. The
10-year relapse-free survival was 87% in the pure mucoid cases
compared with 54% for those with mixed mucoid cancers. The
two 'relapses' in the patients with pure mucoid tumours were both
non-mucoid primary carcinomas in the contralateral breast. Figure
2 shows the overall survival. The pure mucoid group had a very
good prognosis with a 10-year overall survival of 100% compared
with 60% in the mixed group. In a multivariate analysis ofpatients
with mixed mucoid carcinomas including tumour size,histological
grade,lymph node status and the proportion ofthe mucoid compo-
nent, the status of the lymph nodes was the most significant vari-
able. However, the percentage of the mucoid component assessed
as a continuous variable was almost statistically significant (P =
0.0537): the higher the percentage mucoid component the more
favourable the prognosis. When the overall survival of mixed
cases was compared with that of 1658 NST cases treated at Guy's
Hospital, there was no difference in outcome (X2 = 0.93,P = 0.33).
Similarly, when overall survival of Grimelius-positive and
Grimelius-negative cases was compared there was no significant
difference (P =0.94).
C CancerResearch Campaign 1997Mucoidbreastcancer 1063
100
CD
C, 0)80
en
a.) ct 60-
c) a)
X 40
16
m 20- E
0
0
I, Ill ,, L,, ,,,, ,-L -I M Pure n n=21
Mixed n=-43
4 8 12
Time years
16 20 24
Figure 2 Overall survival of patients with pure and mixed mucoid
carcinomas. X12 = 10.86, P< 0.001
Table 3 Histological features of pure and mixed mucoid carcinomas
Pure Mixed
n 24 49
Mucoid grade
I 19 28
11 5 20
III 0 1
Associated tumour
Ductal NST
_ 15
11 _ 23
III 6
Lobular - 3
Neuroendocrine 2
Grimelius staining positive 6 (25) 7 (14)
Type
A 14 (58) 31 (63)
B 7 (29) 13 (27)
AB 3 (13) 5 (10)
Numbers in parentheses are percentages.
The histopathological features of the carcinomas are summa-
rized in Table 3. The mucoid element was usually well differenti-
ated with little nuclearpleomorphism and alow mitotic rate. Using
a modified Bloom and Richardson system (Elston et al, 1982), the
majority of the pure mucoid carcinomas were grade I, but a few
were graded as LI. The mucoid component in over half of the
mixed cases was also classified as grade I. The grade ofthe associ-
ated infiltrating carcinoma was usually similar to that of the
mucoid component but in 16 cases was less well differentiated: II
rather than I in 11 cases and III rather than II in five cases.
The proportion of mucoid carcinoma in the mixed tumours
ranged from 10-99%. Tumours with less than 10% mucoid
component were not included. In the majority of mixed tumours
(32 out of49), the mucoid component accounted for 50% or more
ofthe infiltrating tumour and in 16 out of49 accounted for 90% or
more. The other component was infiltrating ductal carcinoma NST
in all but five cases; in three the second component was infiltrating
lobular carcinoma, and in two the appearance was that of a carci-
noma with neuroendocrine features.
The growth pattern of the mucoid component varied consisting
ofribbons, small tubules, cribriform areas and occasionally large,
solid islands. Only a relatively small proportion of tumours were
positive with the Grimelius stain. In all these cases, the malignant
cells were uniform with slightly granular cytoplasm and arranged
in small or sometimes larger solid islands consistent with the type
B mucoid carcinoma (Capella et al, 1980). In the two mixed
tumours with a non-mucoid neuroendocrine component and one
other mixed tumour with an invasive non-specific type non-
mucoid component, there was positive Grimelius staining
throughout the tumour. In all the other mixed tumours, the non-
mucoid component was not argyrophilic.
Associated ductal carcinoma in situ (DCIS) was present in two-
thirds of the cases. In both pure mucoid and mixed cases, this
element contained various amounts of intraluminal mucous secre-
tion. In some, there was none, but in others abundant amounts of
mucin grossly distended the involved ducts and in several cases
mucin was extravasated into the surrounding stroma. The malig-
nant cells lining the ducts were in most cases well or moderately
differentiated with a solid, micropapillary, cribriform or clinging,
and in one case intracystic, papillary growth pattern. In the two
mixed cases with a Grimelius positive non-mucoid component and
in three other pure Grimelius positive mucoid carcinomas, the
DCIS was also Grimelius positive.
Calcification was seen in sections from 11 tumours. It was
present within the associated DCIS component in eight and in the
mucoid stroma in two and in the stroma of the associated infil-
trating ductal component in one.
The appearance of the lymph node metastases was compared
with that of the primary tumours to ascertain in the mixed
tumours the component that was responsible for spread. It was
noted that in the majority of mixed primary tumours the two
components merged, with the morphology and arrangement of
the malignant cells being similar but lacking the stromal mucin in
the non-mucoid component. When the non-mucoid component
was of higher grade, however, the malignant cells showed more
pleomorphism and a higher mitotic rate. The metastases in most
of the cases resembled the non-mucoid component, although in
the case of some very small metastatic deposits comparison was
difficult. In four cases, the metastases contained a definite
mixture of mucoid and non-mucoid areas, and in one of these
cases a large nodal deposit showed a mixture; however, in a
smaller deposit, although the pattern of malignant cells was
similar, no mucin was present. Of the three cases of pure mucoid
carcinoma with nodal metastases, one ofthe metastases was pure
mucoid and the two other deposits were very small but contained
no detectable mucin.
DISCUSSION
This study has once again confirmed the very favourable prognosis
associated with pure mucoid carcinoma, which is not shared by
mixed mucoid carcinoma. Adequate sampling of carcinomas with
a mucoid appearance is essential, and strict diagnostic criteria
should be adhered to. In this study, even ifonly an extremely small
proportion of the infiltrating tumour was not surrounded by
mucoid stroma, it was excluded from the category, and the original
diagnosis was changed from pure to mixed mucoid in four cases. It
is generally recommended that if 90% of the carcinoma is of one
histological type the tumour should be so designated (NHSBSP
1995); but this does not appear to be applicable to mucoid carci-
nomas. A further criterion proposed for the diagnosis of pure
mucoid carcinoma is that a minimal proportion of the volume of
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the tumour should consist of mucin; 30% has been suggested by
Rasmussen (1985) and 50% by Silverberg et al (1971).
A recent study of the relative prognostic significance of histo-
logical tumour type and grade in mammary carcinomas found that
patients with grade II pure mucoid carcinomas fared significantly
worse than those with grade I tumours (Pereira et al, 1995), but in
our series the small number ofpatients with grade II mucoid carci-
nomas did well. This may be because the criteria for diagnosing
pure mucoid carcinoma were so strict. In mixed lesions, the
percentage ofthe mucoid component was found to be a prognostic
feature (although this did not quite reach statistical significance),
with an increasing proportion ofmucoid element being associated
with a more favourable outcome. Nevertheless, when 90% or more
ofthe infiltrating carcinoma was mucoid, the survival rates did not
match those of the pure tumours. This is in agreement with one
study which found that when patients were divided into those with
pure mucoid, mixed and minimal mucoid component, survival
rates were better in those with tumours having a proportionally
greater gelatinous element (Melamed et al, 1961). In contrast,
another series found no impact on prognosis when patients with
tumours containing 50-75% ofmucoid component were compared
with those having more than 75% (Andre et al, 1995). It has also
been suggested thatthe actualproportion ofmucinproduced within
the tumour may be ofprognostic significance (Clayton 1986).
In the mixed tumours, the grade of the non-mucoid component
was similar to that ofthe mucoid element in most but in one-third
ofcases the former was less well differentiated. Rasmussen (1985)
also noted that the non-mucoid component often appeared more
anaplastic. Probably, as previously suggested, there is a morpho-
logical continuum with all mixed tumours starting as pure lesions
and the non-mucoid component developing at a later stage (Andre
et al, 1995).
Since the publication of Capella's study, classifying mucoid
carcinomas as type A, B and AB (Capella et al, 1980) others have
tried with variable success to divide these lesions on the basis of
morphology or argyrophilia (Rasmussen et al, 1985, 1987;
Ferguson et al, 1986; Coady et al, 1989; Scopsi et al, 1994).
Approximately one-third of mucoid carcinomas are argyrophilic
and this is almost entirely confined to those Capella type B carci-
nomas. Neither argyrophilia nor morphology appear to be ofprog-
nostic significance.
Clayton (1986) suggestedthatlowercellularity (10% orless) with
more mucin production denoted a more favourable prognosis. As
argyrophilic tumours are more cellular, this type may have a higher
malignant potential (Coady et al, 1989). However, Rasmussen et al
(1985) noted that lymph node metastases were less frequent in
patients with argyrophilic tumours but found no difference in prog-
nosis. Thus, it appears that by far the most important prognostic
feature is the presence orabsence ofa mixed component.
Little attention has been paid to ductal carcinoma in situ in asso-
ciation with mucoid carcinomas. Rasmussen commented thatDCIS
in pure mucinous carcinomas often consisted of cystically dilated
ducts with abundant intraluminal mucin (Rasmussen, 1985). It has
been recently suggested that different variants ofDCIS may repre-
sent precursors to the different Capella types (Malufet al, 1995) i.e.
a mucin-rich DCIS, often with mucocoele-like lesions being asso-
ciated with type A and a distinctive form of papillary DCIS with
type B. The latter has a solid pattern and a high incidence of
Grimelius and chromogranin positivity. Various patterns of DCIS
exhibiting different amounts ofmucin production were seen in this
study in association with both Type A and Type B tumours and pure
and mixed carcinomas. In five cases,both the DCIS andinfiltrating
component was Grimelius positive but only one was of true papil-
lary pattern. Further histological, histochemical and immunohisto-
chemical evaluation of the DCIS component of both pure and
mixed mucoid carcinomas is currently under way and is the subject
ofa separate study. Correlation ofthe different pattems and grades
ofDCIS with their infiltrating components is of interest because it
may yield information as to the malignant potential of pure DCIS.
This could be valuable in helping to select appropriate therapy for
this latter condition which is currently being diagnosed with
increasing frequency.
The very favourable prognosis associated with pure mucoid
carcinomas has been shown repeatedly but it has been questioned
occasionally. Rosen et al (1980) claimed that if patients are
followed for more than 10 years a significant proportion recur
(Rosen et al, 1980). In our study, after a median follow-up of 10.5
years, none of the patients with operable pure mucoid carcinoma
had died and the only relapses consisted ofthedevelopment oftwo
subsequent non-mucoid contralateral primary breast cancers.
Axillary nodal metastases have consistently been found more
frequently in patients with mixed mucoid carcinomas than in those
who have pure mucoid lesions. Indeed, it has been suggested that
lymph node metastases in a patient with pure mucoid carcinoma
indicate that the tumour is really an inadequately sampled mixed
lesion (Rasmussen et al, 1987). However, some metastases from
both pure and mixed tumours have a mucoid appearance,
suggesting that this component does have a metastatic potential,
even if this is low. In relation to this, Clayton noted that axillary
metastases from pure mucoid carcinomas resembled the primary
tumour, but subsequent recurrences and distant metastases were
sometimes less differentiated and some, while resembling the
mucoid primary, lacked mucin (Clayton, 1986). At present well-
differentiated carcinomas and those of special type (including
mucoid tumours) with a favourable prognosis are being diagnosed
more frequently, partly because of mammographic screening.
Such tumours are usually suitable for breast-conserving tech-
niques and in view oftheir very favourable prognosis may well be
treated adequately by excision. The need for additional radio-
therapy and axillary clearance has been questioned and is now
being addressed in prospective randomized trials.
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